Celsion Corp. , a Nasdaq-listed company specialized in oncology, sees significant market potential of immuno-oncology therapy in China, where the company extended a collaboration with Zhejiang Hisu
Zhejiang Hisun Pharmaceutical Co. Ltd. has inked another international partnership, this time with US-based Nascent Pharmaceuticals LLC to strengthen its China oncology pipeline under a technolo